[Othe suitability of paraoxon miosis of the human eye for testing of cholinesterase reactivators].
D000293:Adolescent; D000328:Adult; D000886:Anthropometry; D002800:Cholinesterase Inhibitors / Q000037:antagonists & inhibitors*; D002802:Cholinesterases / Q000378:metabolism*; D002986:Clinical Trials as Topic; D005123:Eye / Q000201:enzymology*; D006801:Humans; D007552:Isotonic Solutions / Q000494:pharmacology; D008297:Male; D008916:Miotics / Q000008:administration & dosage*; D011220:Pralidoxime Compounds / Q000494:pharmacology; D011680:Pupil / Q000502:physiology*; D011726:Pyridinium Compounds / Q000494:pharmacology
D002800:Cholinesterase Inhibitors; D007552:Isotonic Solutions; D008916:Miotics; D011220:Pralidoxime Compounds; D011726:Pyridinium Compounds; D002802:Cholinesterases
Uber die Eignung der Paraoxon-Miosis des menschlichen Auges zur Testung von Cholinesterase-Reaktivatoren.